Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 209-235-5 | CAS number: 562-74-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Additional toxicological data
Administrative data
- Endpoint:
- additional toxicological information
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with generally accepted scientific standards and described in sufficient detail
Data source
Reference
- Reference Type:
- publication
- Title:
- Human skin penetration of the major components of Australian tea tree oil applied in its pure form and as a 20% solution in vitro
- Author:
- Cross S. E., Russell M, Southwell I, Roberts M. S.
- Year:
- 2 007
- Bibliographic source:
- European Journal of Pharmaceutics and Biopharmaceutics 69 (2008) 214-222
- Report date:
- 2007
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- - Principle of test: Address the lack of percutaneous penetration and disposition data of the components of tea tree oil (TTO).
- Short description of test conditions: TTO was applied as the neat oil and as a 20% solution in ethanol to the skin of three different female donors under "in use" application conditions and followed the penetration over a 24-h period. The main component of TTO is terpinen-4-ol.
- Parameters analysed / observed: skin penetration, retention of TTO components in the epidermis, examined the effect of partial occlusion - GLP compliance:
- not specified
Test material
- Reference substance name:
- Melaleuca Alternifolia /Tea Tree) Leaf oil
- Cas Number:
- 68647-73-4
- IUPAC Name:
- Melaleuca Alternifolia /Tea Tree) Leaf oil
Constituent 1
- Specific details on test material used for the study:
- Tea tree oil (TTO) was supplied by the Australian Tea Tree Industry Association. 100% pure TTO was used and a 20% solution in ethanol in the epidermal penetration studies.
Results and discussion
Any other information on results incl. tables
Epidermal penetration: Non-occluded application
Terpinen-4 -ol was found to penetrate epidermal membranes and could be quantified in the receptor phase in samples from each of the three different skin donors. The three donors showed varying
penetration of terpinen-4-ol (140-310 µg/cm² or 3.6–8.0% of the applied amount) over the 24 -h period following application of the pure oil. Following application of the 20% TTO formulation, amounts of
terpinen-4-ol in the receptor phase after 24 h were found to represent 18-33 lg/cm2 or 1.1–1.9% of the applied amount of TTO. Statistical differences in the penetration rate of terpinen-4 -ol was found for the three donor skins at all time points following application of the pure oil, with one skin much more permeable than the other two (p < 0.05). However, following application of the 20% TTO formulation, the more permeable skin only showed significant differences in the penetration of terpinen-4 -ol to the other two donors in the 4–12 h time period (p < 0.05).
Epidermal penetration: Partially occluded application
Following partial occlusion of the donor chamber and application of the pure oil formulation, the test substance could be detected in the receptor phase at 531.4 µg/cm². At 12 h the average absorption of the test substance following application of pure TTO was 289.72 µg/cm². Compared to non-occluded application conditions, at the 24 -h time point the mean amount of the test substance detected in the receptor phase increased approximately 2.5 -fold.
Epidermal retention: Non-occluded application
Retention of the test substancel following application of pure TTO to the three skin donors varied between 4.1 and 6.6 lg/cm2 (0.1–0.2% of the applied amount) and following application of the 20% formulation
varied between 0.25 and 0.38 lg/cm2 (<0.02% of the applied amount). There was a slight variability in the retention of TTO between the three different skin donors.
Epidermal retention: Partially occluded application
Following partial occlusion of the donor chamber compartment of the Franz cell, there was a significant increase in the amount of the test substance recovered from the epidermis following application of the pure oil. The increase in recovery of the test substance from within the epidermis in the donor chamber partially occluded experimental system was approximately three times that seen following non-occluded application.
Our data show that, under normal ‘in use’ conditions, approximately 2–4% of identifiable applied TTO components can be found either permeating the skin into receptor fluid (1.7–3.8%) or retained within the epidermis (0.23–0.37%) after 24 h application under normal ‘in use’ conditions. Under partially occluded conditions, the transdermal uptake of identifiable TTO components increased to 7% of the applied dose, 6.8% in the receptor phase and 0.3% remaining within the epidermis.
Applicant's summary and conclusion
- Conclusions:
- The studies demonstrated that terpinen-4-ol was able to penetrate humna epidermis and be recovered in the receptor phase solution.
In conclusion, the current study has shown that following application of pure TTO under normal ‘in use’ conditions, a small quantity of TTO components, 1.1–1.9% and 2–4% of the applied amount following application of a 20% TTO solution and pure TTO respectively, were found to penetrate into or through human epidermis. The largest TTO component penetrating the skin was terpinen-4-ol. Following partial occlusion of the application site, this penetration increased to approximately 7% of the applied TTO. These data should now be used to expand risk assessment profiles of the use of TTO and reduce speculatoin that all lipophilic components of TTO are assumed to freely penetrate the skin. - Executive summary:
The safety of topical application of Australian tea tree Oil (TTO) is confounded by a lack of transdermal penetration data, which adequately informs opinions and recommendations. In this study we applied TTO in its pure form and as a 20% solution in ethanol in vitro to human epidermal membranes from three different donors, mounted in horizontal Franz-type diffusion cells, using normal ‘in use’ dosing conditions (10 mg/cm2). In addition, we examined the effect of partially occluding the application site on the penetration of TTO components. Our data showed that only a small quantity of TTO components, 1.1–1.9% and 2–4% of the applied amount following application of a 20% TTO solution and pure TTO, respectively, penetrated into or through human epidermis. The largest TTO
component penetrating the skin was the test substance. Following partial occlusion of the application site, the penetration of the test substance increased to approximately 7% of the applied TTO. Measurement of the rate of evaporation of tea tree oil from filter paper (7.4 mg/cm²) showed that 98% of the oil evaporated in 4 hours. Overall, it is apparent that the penetration of TTO components through human skin is limited.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.